• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在外显子/基因组测序中发现的错误归因的亲子关系:当前的临床实验室实践和标准化的机会。

Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.

机构信息

University of California, Los Angeles, Los Angeles, CA, USA.

ARUP Laboratories, University of Utah, Salt Lake City, UT, USA.

出版信息

Genet Med. 2019 Apr;21(4):861-866. doi: 10.1038/s41436-018-0265-4. Epub 2018 Sep 14.

DOI:10.1038/s41436-018-0265-4
PMID:30214068
Abstract

PURPOSE

Clinical laboratories performing exome or genome sequencing (ES/GS) are familiar with the challenges associated with proper consenting for and reporting of medically actionable secondary findings based on recommendations from the American College of Medical Genetics and Genomics (ACMG). Misattributed parentage is another type of unanticipated finding a laboratory may encounter during family-based ES/GS; however, there are currently no professional recommendations related to the proper consenting for and reporting of misattributed parentage encountered during ES/GS.

METHODS

We surveyed 10 clinical laboratories offering family-based ES/GS regarding their consent language, discovery, and reporting of misattributed parentage.

RESULTS

Many laboratories have already developed their own practices/policies for these issues, which do not necessarily agree with those from other labs.

CONCLUSION

There are several other possibilities besides true misattributed parentage that could result in similar laboratory findings, and laboratories often feel they lack sufficient information to make formal conclusions on a report regarding the true genetic relatedness of the submitted samples. However, understanding the genetic relatedness (or lack thereof) of the samples submitted for family-based ES/GS has medical relevance. Therefore, professional recommendations for the appropriate handling of suspected misattributed parentage encountered during ES/GS are needed to help standardize current clinical laboratory practices.

摘要

目的

进行外显子组或基因组测序(ES/GS)的临床实验室熟悉基于美国医学遗传学与基因组学学会(ACMG)建议,对有医学意义的次要发现进行适当知情同意和报告所面临的挑战。亲子关系错误是实验室在进行基于家族的 ES/GS 时可能遇到的另一种意外发现类型;然而,目前尚无关于在 ES/GS 过程中遇到的亲子关系错误的适当知情同意和报告的专业建议。

方法

我们调查了 10 家提供基于家族的 ES/GS 的临床实验室,了解他们在亲子关系错误的知情同意语言、发现和报告方面的情况。

结果

许多实验室已经针对这些问题制定了自己的实践/政策,这些政策不一定与其他实验室的政策一致。

结论

除了真正的亲子关系错误之外,还有其他几种可能性会导致类似的实验室发现,而且实验室通常认为他们缺乏足够的信息来对报告中提交样本的真实遗传关系做出正式结论。然而,了解提交进行基于家族的 ES/GS 的样本的遗传关系(或缺乏遗传关系)具有医学相关性。因此,需要专业建议来妥善处理 ES/GS 过程中遇到的疑似亲子关系错误,以帮助规范当前的临床实验室实践。

相似文献

1
Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.在外显子/基因组测序中发现的错误归因的亲子关系:当前的临床实验室实践和标准化的机会。
Genet Med. 2019 Apr;21(4):861-866. doi: 10.1038/s41436-018-0265-4. Epub 2018 Sep 14.
2
Misattributed parentage identified through diagnostic exome sequencing: Frequency of detection and reporting practices.通过诊断外显子组测序鉴定的错误归因的亲权关系:检测和报告实践的频率。
J Genet Couns. 2022 Jun;31(3):631-640. doi: 10.1002/jgc4.1530. Epub 2021 Nov 26.
3
Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.了解美国基因组测序实验室次要发现报告实践的差异。
AJOB Empir Bioeth. 2018 Jan-Mar;9(1):48-57. doi: 10.1080/23294515.2017.1405095. Epub 2017 Dec 21.
4
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.临床外显子组和基因组测序中次要发现报告的建议,2016年更新版(美国医学遗传学与基因组学学会次要发现v2.0):美国医学遗传学与基因组学学会政策声明
Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17.
5
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会(ACMG)关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.1清单:一项政策声明
Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.
6
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).临床外显子组和基因组测序中次要发现报告的建议,2021年更新:美国医学遗传学与基因组学学会(ACMG)政策声明
Genet Med. 2021 Aug;23(8):1391-1398. doi: 10.1038/s41436-021-01171-4. Epub 2021 May 20.
7
Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).基于家庭的临床基因组检测中评估关系(或怀疑关系错误归因)时需考虑的要点:美国医学遗传学与基因组学学会(ACMG)声明
Genet Med. 2020 Aug;22(8):1285-1287. doi: 10.1038/s41436-020-0821-6. Epub 2020 May 14.
8
Copy number alterations involving 59 ACMG-recommended secondary findings genes.涉及 59 个 ACMG 推荐的次要发现基因的拷贝数改变。
Clin Genet. 2020 Dec;98(6):577-588. doi: 10.1111/cge.13852. Epub 2020 Oct 10.
9
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).ACMG SF v3.2 临床外显子组和基因组测序中报告次要发现的列表:美国医学遗传学与基因组学学会 (ACMG) 的政策声明。
Genet Med. 2023 Aug;25(8):100866. doi: 10.1016/j.gim.2023.100866. Epub 2023 Jun 22.
10
Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.从基因组和外显子组测序数据中发现的具有医学意义的偶然发现的频率和处理方法:系统评价。
Physiol Genomics. 2021 Sep 1;53(9):373-384. doi: 10.1152/physiolgenomics.00025.2021. Epub 2021 Jul 12.

引用本文的文献

1
Misattributed paternity discovery: A critique of medical organizations' recommendations.错误认定亲子关系的发现:对医学组织建议的批判
Am J Hum Genet. 2025 Mar 6;112(3):492-507. doi: 10.1016/j.ajhg.2025.01.006. Epub 2025 Feb 3.
2
Development of a coding SNP panel for tracking the origin of whole-exome sequencing samples.用于追踪全外显子组测序样本来源的编码单核苷酸多态性(SNP)面板的开发。
BMC Genomics. 2024 Feb 5;25(1):142. doi: 10.1186/s12864-024-10052-4.
3
Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).
神经发育障碍的遗传和代谢研究:加拿大医学遗传学家学院(CCMG)的立场声明。
J Med Genet. 2023 Jun;60(6):523-532. doi: 10.1136/jmg-2022-108962. Epub 2023 Feb 23.
4
Exome/Genome Sequencing in Undiagnosed Syndromes.外显子组/基因组测序在未确诊综合征中的应用。
Annu Rev Med. 2023 Jan 27;74:489-502. doi: 10.1146/annurev-med-042921-110721.
5
The full spectrum of ethical issues in pediatric genome-wide sequencing: a systematic qualitative review.儿科全基因组测序中的伦理问题全景:系统定性综述。
BMC Pediatr. 2021 Sep 6;21(1):387. doi: 10.1186/s12887-021-02830-w.
6
Genetic Testing in Neurodevelopmental Disorders.神经发育障碍中的基因检测
Front Pediatr. 2021 Feb 19;9:526779. doi: 10.3389/fped.2021.526779. eCollection 2021.